Last reviewed · How we verify
NCT06035666: RESILIENT
REducing Stress and Improving professionaLs' vItality Using innovativE iNtervenTions
NA trial testing Your World in Mental Health Issue in 500 participants. Status unknown.
1 January 2024
Quick facts
| Lead sponsor | Erasmus Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 500 |
| Start date | 1 January 2023 |
| Primary completion | 1 January 2024 |
| Estimated completion | 1 January 2024 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Your World
- Control app
Conditions studied
- Mental Health Issue — all drugs for Mental Health Issue →
- Healthy Lifestyle — all drugs for Healthy Lifestyle →
- Stress, Psychological — all drugs for Stress, Psychological →
Sponsor
Erasmus Medical Center
Who can join
Adults 18 to 66, any sex, with Mental Health Issue or Healthy Lifestyle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction Up to half of hospital employees worldwide are experiencing symptoms of burnout. Therefore, interventions to improve mental health among hospital workers are urgently needed. Your World is an inexpensive and easy-to-use intervention that aims to reduce stress and increase resilience among hospital employees. Your world uses a blended approach, which includes a real-life personal session and challenges in the Your World app (for smartphone). Hypothesis The investigators hypothesize that Your World will improve resilience and well-being and reduce stress among hospital employees. Research objectives Main objective \- Does Your World reduce stress among hospital employees as measured by the PSS-10? Design Randomised controlled trial Population Employees of the Erasmus University Medical Center including students and volunteers Methods and study procedures Five hundred participants will be randomized 1:1 to receive either Your World (intervention) or the control app (control). In the intervention group, subjects will participate in one 'vitality session' before installing the app. At baseline and after 3 months hair samples questionnaires will be collected among the participants of both groups. At 6 months, same questionnaires will be collected. Burden and risks There are no risks associated with participation in this study. The questionnaires can be filled out online in 15 minutes, hair collection takes 5 minutes. The vitality sessions take 1 hour and the use of the app takes 5 minutes a day.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06035666
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mental Health Issue
Currently open trials in the same condition.
- NCT07129070 — Just-in-Time Training for Youth Mentors · NA · recruiting
- NCT07075081 — Gii'Igoshimong: Sitting With Your First Family · Phase 2 · recruiting
- NCT07160439 — Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors · NA · recruiting
- NCT06385457 — The Effects of Mindhelper.dk: a Self-guided Digital Mental Health Promotion Service Targeting Young People · NA · recruiting
- NCT06442774 — MamaConecta: Digital Tool for Maternal Mental Health · NA · recruiting
Other Erasmus Medical Center trials
Trials by the same sponsor.
- NCT07406269 — Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery · NA · not yet recruiting
- NCT07402109 — CBCT Guided Markerless SBRT for Renal Cell Cancer · NA · recruiting
- NCT07383194 — Prediction Models for LDLT Outcomes · not yet recruiting
- NCT07426575 — Evaluating the Usability of New Dialysis Bags · not yet recruiting
- NCT07329296 — The Regenerative Capacity of the Donor Liver After Living Donor Liver Transplantation: an Ambidirectional Cohort Study · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06035666 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Erasmus Medical Center
- Last refreshed: 13 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06035666.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing